Dianthus Therapeutics (DNTH) Misses Q1 EPS by 54c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.54). Revenue for the quarter came in at $870 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral